In line with previous findings, all NTRK gene family fusions involved the 5′ end of the fusion partner and the 3′ end of NTRK preserving the tyrosine kinase domain resulting in constitutive activation of TRK signaling which ultimately leads to tumor proliferation and resistance to apoptosis [7]. This evidence concerns the gene NTRK1 and neoplasm.